Clinical serum metabolomics study on fluoxetine hydrochloride for depression

Volume: 746, Pages: 135585 - 135585
Published: Feb 1, 2021
Abstract
Fluoxetine hydrochloride is one of the familiar antidepressants of the second generation and has the effect of inhibiting the reuptake of 5-hydroxytryptamine by central nervous system. Both clinical trials and animal experiments show that it has good antidepressant effect, but there are few reports on its clinical efficacy in treating depression patients from the perspective of metabolomics. This study aimed at evaluating the antidepressant...
Paper Details
Title
Clinical serum metabolomics study on fluoxetine hydrochloride for depression
Published Date
Feb 1, 2021
Volume
746
Pages
135585 - 135585
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.